Join us for a global conversation with innovators, investors, partners and thought leaders to discover and accelerate next-gen potential solutions for future pandemics, emerging pathogens, and other known and unknown threats. This event is part of  BLUE KNIGHT™, a joint initiative between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services.  This year’s Symposium will be hosted in association with the 2023 BIO International Convention.

Attendance is limited so secure your spot and RSVP today to take part in this global event. More information on this year’s Symposium will be announced shortly. In the meantime, learn more about the engagement opportunities we have available this year for early-stage companies, investors, funders and strategic partners below.

Register

This program is a product of a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.